viernes, 7 de enero de 2011

Delving Into the Broadway Playbook to Stay Open

Delving Into the Broadway Playbook to Stay Open

In the face of daunting odds — odds that led nine Broadway shows to close on Sunday — stands “Lombardi,” the play about the legendary Green Bay Packers coach that is the only brand-new drama to survive the fall season. The producers of “Lombardi” made the bullish announcement on Tuesday that they would extend ticket sales through June 19, even though the winter is traditionally a graveyard for plays like this one, which lack audience-drawing stars.
Sara Krulwich/The New York Times
“Lombardi,” with Dan Lauria in the title role, has tried to reach beyond the usual theater crowd.
Sara Krulwich/The New York Times
Partly to reduce its costs, “Rock of Ages” will move to the smaller Helen Hayes Theater.
Sara Krulwich/The New York Times
Al Pacino and “The Merchant of Venice” return in February.
So what fills the producers with a fighting spirit that Vince Lombardi would admire? Confidence in a marketing strategy that is aimed at sports fans and men, not just the usual theater crowd. The producers of this biographical play have already booked visits by fans from colleges with proud sports traditions, like Fordham (Lombardi’s alma mater), Syracuse and Boston College, and they have promoted the show as a kind of leadership training to draw in CBS sales executives on a team-building retreat and members of the Miami Dolphins who were in town to play the Jets last month.
The producers are also reaching a more traditional Broadway crowd by promoting their two lead actors, Dan Lauria as Lombardi, and Judith Light as his wife, Marie, who are giving critically praised performances. (Critics were more mixed about the rest of the show.) And they have kept costs low, at slightly more than $200,000 a week, which helps weather nights with many empty seats.
“You need to have a plan — maybe a clever plan, maybe a surprising one, but some kind of plan — to survive on Broadway these days when you’re not a big, brand-name musical,” said Tony Ponturo, one of the lead producers of “Lombardi.” “For us, we have Vince Lombardi and his leadership sayings, which still intrigue people.”
Not only has the play attracted executives from law firms and corporations like CBS, he said, but it has also led some groups to build fund-raising events around attending the show. After many of these performances with large groups, Mr. Lauria and often Ms. Light and other actors will take part in special audience talkbacks to delve further into the Lombardi mythos. The show has also taped “vignettes” with Mr. Lauria as Lombardi that will run on the NFL Network during the playoff season, Mr. Ponturo said.
“Lombardi” is one of several Broadway shows whose producers have taken unusual steps to try to keep running through the 2010-11 theater season. While shows so far are bringing in 3.6 percent more in box office receipts than Broadway was earning at this point last season, and while attendance is up 3.8 percent, much of that growth is attributed to a relatively small number of musicals: war horses like “Wicked” and “The Lion King,” which set box office records last week; newer productions like “Memphis,” the 2010 Tony Award winner for best musical; and the lavish spectacle “Spider-Man: Turn Off the Dark,” which is selling out though it is still in previews.
One play, “The Merchant of Venice,” a critical and commercial hit starring Al Pacino as Shylock, had been scheduled to close for good this Sunday because Mr. Pacino had a film commitment. But its producers decided to negotiate a hiatus with its cast, crew and theater owners, closing for three weeks and then reopening Feb. 1 through 20 because, as the producer Jeffrey Richards said, “we’ve been turning away people.”
Joey Parnes, the executive producer of “Merchant,” said that the hiatus would cost “considerably less” than $500,000 in rent to the Broadhurst Theater and other expenses; the show’s box office, by comparison, had been regularly bringing in more than $1 million a week in ticket sales.
“We’re still negotiating details,” Mr. Parnes said, “but the hiatus looks like a wise strategy that will allow more people to see the show and earn more money for investors.”
Another Broadway hit, the Beatles tribute show “Rain,” worked out its own atypical extension by changing theaters. “Rain,” which earned $1.4 million last week for 11 performances, will still close at the Neil Simon Theater on Jan. 15, but then move five blocks south to the Brooks Atkinson Theater and resume performances there on Feb. 8 for at least 16 more weeks. The current tenant of the Brooks Atkinson, “Rock of Ages,” which has been running there since March 2009, will close on Sunday and move to the Helen Hayes Theater, where performances will start in March.
The “Rain” producers struck the deal with the Nederlander Organization, which owns the Neil Simon and eight other Broadway houses, including the Atkinson. While the company earns rent and a piece of the ticket sales, its producing arm, Nederlander Presentations, also has a sizable financial investment in “Rain,” though no one would say how much. So it was in the interest of the organization to keep “Rain” going.
“Rock of Ages” has had an open-ended run and sells out regularly on weekends, but has also grappled with the challenge of filling even three-quarters of the 997-seat Atkinson Theater on weeknights — the sort of struggle that some shows face the longer they run. The idea of moving to a smaller theater like the 597-seat Helen Hayes also intrigued the “Rock of Ages” producers, they said, because their weekly operating costs would be reduced. (The front-of-house staff, advertising, technical costs and other expenses would most likely be lower in a theater with fewer seats.)
Another musical, “American Idiot,” has faced an uncertain future this winter, as ticket sales have been mixed during slow tourist weeks. The show turned to its own ace in the hole, Billie Joe Armstrong, the lead singer of the band Green Day whose music is the basis of the rock opera. Mr. Armstrong, who stepped into the “American Idiot” cast briefly last fall and jolted the box office, has now returned to the role of St. Jimmy through Feb. 27 (though he will be out for some performances), helping the show ride out the two traditionally slowest-selling months of the year.
Not all inventive business strategies have paid off entirely, though. The producers of the play “La Bête” made the unusual decision last year to undertake a single production for both London and New York, meaning that investors put their money into both runs rather than wait to see if the show succeeded in its first outing, in the West End last summer, before investing in the Broadway run. In doing so, the producers said they were able to save at least $1 million by spreading out their capitalization costs and building the physical production in England, where labor tends to be less expensive.
But while “La Bête” drew sizable crowds in London, it has struggled to build an audience in New York. The producers announced that the show would close five weeks ahead of schedule, on Sunday, though in a statement this week they said that the business model remained sound.
“ ‘La Bête’ could have easily played a short engagement at, say, BAM or an Off Broadway venue for three or four weeks,” said the producers, Sonia Friedman and Scott Landis. “Instead, our model allowed us to present a challenging play like ‘La Bête’ commercially for six months, between the West End and Broadway; have it seen by over 128,000 theatergoers; and return a healthy portion of its capitalization to our investors.”
In other words, “La Bête” will end up losing money — as two-thirds of Broadway shows typically do. Mr. Ponturo, the “Lombardi” producer, said that for all his marketing plans, he could not say if the show would turn a profit.
“We’re drawing a broad audience that gives us encouragement,” he said, “but we still know it’ll be tough to fill seats through the winter.”

Evolución en el estudio del sustrato cerebral de las funciones cognitivas y el desarrollo

Evolución en el estudio del sustrato cerebral de las funciones cognitivas y el desarrollo imprimir
30/12/2010Redacción
Cada vez existen más pruebas en la bibliografía sobre la implicación del cerebelo en las funciones cognitivas superiores y el control de la expresión emocional y la conducta. Cuando se producen lesiones o anomalías del desarrollo del cerebelo, algunos pacientes presentan un cortejo sintomático denominado síndrome cognitivo afectivo cerebeloso, secundario a la hipótesis de la dismetría del pensamiento, la cual aparece en la base de algunos trastornos psiquiátricos, entre ellos la esquizofrenia, en los que se han visto alteraciones en la estructura de este órgano. Las alteraciones son consistentes y están asociadas a patología del vermis posterior.

Sin embargo, cuando se lleva a cabo una lectura crítica de la bibliografía científica, parece existir una clara división entre aquellos que plantean la participación del cerebelo en funciones cognitivas y emocionales y los que cuestionan esta afirmación, limitando la participación del cerebelo exclusivamente al componente motor implicado en toda conducta. 

Actualmente existe una situación en la que los datos que todos los días se obtienen en investigación no encuentran modelos explicativos claros que puedan satisfacer a la dispersión de datos, a veces tan incongruentes y difíciles de encajar unos con otros y que deberían trazar relaciones firmes entre síntomas y funciones cerebrales.

[Rev Neurol 2010]
Hernáez-Goñi P, Tirapu-Ustárroz J, Iglesias-Fernández L y Luna-Lario P
Palabras Clave: Autismo. Déficit de atención. Depresión mayor. Esquizofrenia. Risa y llanto patológicos. Síndrome cognitivo afectivo cerebeloso. Trastorno bipolar. Vermis

Diferencias raciales y socioeconómicas en pacientes con Parkinson

Diferencias raciales y socioeconómicas en pacientes con Parkinson imprimir
28/12/2010Redacción
Los afroamericanos y aquellos con un menor nivel socioeconómico parecen tener un parkinsonismo más grave y con mayores niveles de discapacidad, según un informe publicado en la revista Archives of Neurology, en el que se estudió a 1.159 pacientes con Parkinson que fueron evaluados por especialistas en trastornos del movimiento entre 2003 y 2008. Menores ingresos y menor nivel educativo se asociaron también con una mayor gravedad de la enfermedad y discapacidad.

Las disparidades también se observaron en los patrones de tratamiento. Se prescribieron menos medicamentos para tratar el Parkinson en la primera visita clínica (61,9% recibieron medicación, en comparación con 77,6% de los pacientes de raza blanca). Entre los pacientes afroamericanos, al 20,6% se les prescribió nuevos medicamentos dopaminérgicos, en comparación con el 41,1% de los pacientes de raza blanca, mientras que un 12,7% de los afroamericanos recibieron tratamiento con antipsicóticos en comparación con el 6,1% de los pacientes blancos.
[Arch Neurol 2010]
Hemming JP, Gruber-Baldini AL, Anderson KE, Fishman PS, Reich SG, Weiner WJ, et al.
Palabras Clave: Afroamericanos. Blancos. Discapacidad. Educación. Nivel socioeconómico. Parkinsonismo. 

Evolución de la anatomía patológica de la enfermedad de Alzheimer

Evolución de la anatomía patológica de la enfermedad de Alzheimer imprimir
28/12/2010Redacción
Investigadores suecos han estudiado el cerebro de un enfermo de alzheimer para observar los depósitos amiloides durante la progresión de la enfermedad y después de la muerte. El resultado de estos análisis, que se publican en la revista Brain, ofrece una imagen detallada de cómo se desarrolla la enfermedad de Alzheimer. Se descubrieron altas concentraciones de placas amiloides en una etapa temprana de la enfermedad, cuando el paciente sufrió una pérdida leve de memoria. Los niveles se mantuvieron sin cambios durante el curso de la enfermedad, en contraste con el metabolismo energético en el cerebro que, como la memoria del paciente, se deterioró progresivamente.
También se observó que la mayor acumulación de placa se acompaña de una reducción en el número de receptores nicotínicos neuronales en el cerebro. Esto demuestra que los receptores se ven afectados desde el principio en el desarrollo de la enfermedad. 
Además, se midieron los cambios inflamatorios en las regiones del cerebro con bajos niveles de placas, amiloide lo que sugiere que los fenómenos de inflamación asociados a la enfermedad de Alzheimer podrían tener una causa diferente,y evolucionar en diferentes fases de la enfermedad, en comparación con la de la acumulación de proteína amiloide.
[Brain 2010]
Kadir A, Marutle A, Gonzalez D, Schöll M, Almkvist O, Mousavi M, et al.
Palabras Clave: Enfermedad de Alzheimer. Depósitos amiloides. Metabolismo energético. Progresión. Receptores nicotínicos

Guía 2011 de la AHA/ASA sobre prevención de la recurrencia del ACV isquémico

Posted: 06 Jan 2011 06:42 PM PST

Ictus, accidente cerebrovascular y enfermedad cerebrovascular aguda son sinónimos de la patología neurológica más común, y que en países desarrollados, constituye una de los tres padecimientos de mayor morbimortalidad. Desde la primera conferencia sobre Prevención y Rehabilitación del Ictus Isquémico en Arizona en 1.996, la American Heart Association (AHA) y American Stroke Association (ASA) propone recomendaciones en forma de guidelines sobre distintos aspectos del manejo de esta patología. En octubre de este año, la revista Stroke adelantó la “Guía 2011 para la Prevención del Ictus Isquémico en pacientes con Ictus o Accidente Isquémico Transitorio (AIT) previo”, actualizando la publicada en el 2.006. Reseñamos las nuevas recomendaciones con sus respectivos nivel de evidencia y recuperamos algunos aspectos ya mencionados en informes previos que vale la pena comentar.
· Primero que nada, remarcar el mensaje inicial que figura en la introducción de la guía. Textualmente expone: “el objetivo de esta guía es proveer a los clínicos las recomendaciones basadas en la más reciente evidencia”.
· Es sabido que la Presión Arterial (PA) debe reducirse en pacientes con ictus, tanto en aquellos con y sin antecedentes de hipertensión arterial (HTA), y que el tratamiento debe iniciarse luego de las 24 horas del evento (Recomendación Clase I; Nivel de Evidencia A -I;A-). El objetivo de cifras de PA debe ser individualizado, aunque mínimas reducciones (por ejemplo, 10/5 mmHg) son beneficiosas. Las cifras consideradas “óptimas” o “normales” por la Joint National Comitte (JNC) son 120/80 mmHg (IIa;B). Tiazidas e IECA, con o sin tiazidas, disponen de evidencia suficientemente buena como para ser los fármacos de elección (I;A). Sin embargo, la nueva recomendación en este tema es que “la elección del fármaco debe ser individualizada según aspectos farmacológicos, existencia de comorbilidades (por ej. albuminuria, enfermedad coronaria, etc)”. Esta nueva apreciación/recomendación está valorada como IIa;B, es decir: teniendo en cuenta la información actualmente disponible, estudios randomizados únicos o no randomizados (Evidencia B), es razonable su aplicación porque los beneficios superan a los riesgos (Clase IIa).
· En referencia a los pacientes con diabetes tipo 2 (DM2), propone como novedad que “aquellos pacientes que presenten un Ictus deben seguir las guías de manejo adecuado de esta patología” (de la American Diabetes Association -ADA-).
· Desde el 2.006 se proponía como “razonable” (IIa;B) iniciar tratamiento con Estatinas en pacientes con Ictus o AIT de origen aterotrombótico sin la presencia de factores preexistentes habituales para su inicio (hipercolesterolemia, comorbilidad coronaria, evidencia de aterosclerosis). El nuevo aporte en este aspecto son los objetivos terapéuticos (IIa;B): “los target terapéuticos de C-LDL son alcanzar una reducción de al menos del 50% o unos valores < 70mg/dl”.
· No han cambiado las recomendaciones en relación al consumo de Alcohol (los pacientes con Ictus isquémico deben suspender la ingesta alcohólica –I;C– y si bien el consumo leve a moderado puede ser beneficioso, no hay que alentar su consumo en pacientes sin dicho antecedente –IIa;B–) y Hábito Tabáquico (fuerte advertencia médica sobre la suspensión del hábito –I;C–, y ofrecer opciones farmacológicas para su abandono –I;A–).
· La referencia al Síndrome Metabólico (SM) en el contexto del ictus isquémico se introduce por primera vez en la guía de prevención de recurrencia. El documento menciona que “no está claro la utilidad del rastreo SM en pacientes con ictus (IIb;C), pero en aquellos que se realice y detecte la alteración propone realizar las recomendaciones habituales no farmacológicas (dieta, ejercicio yreducción de peso) y controlar adecuadamente los factores de riesgo como HTA y dislipidemia (I;A)”.
· No hay cambios en relación al punto “Enfermedad Carotídea” (EC) sintomática (la EC detectada en el contexto del ictus o AIT siempre es clasificada como “sintomática”). Resumiendo: estenosis carotídea del 70-99% debe tratarse siempre (I;A) y entre 50 y 69% debe intentarse valorando comorbilidades, riesgo quirúrgico, etc. (I;B). El tratamiento quirúrgico (endarterectomía carotídea) es de elección siempre que el riesgo de morbimortalidad periprocedimiento (RMMPp) del servicio donde se haga el procedimiento sea <6% (I;A). La angioplastia carotídea con colocación de stent es una alternativa cuando halla dificultades anatómicas, riesgo quirúrgico elevado, estenosis postendarterectomía, etc. (para considerarse alternativa debe existir un RMMPp <4%) (I;B). No está indicada el by-pass carotídeo en casos de obstrucción total (III;A).
· En el apartado Fibrilación Auricular (FA) recordamos la recomendación I;A del 2.006 de anticoagular con warfarina (W) tanto a los pacientes con FA paroxísitica como permanente (para INR entre 2 y 3) y que aquellos que no pueden ingerir los antagonistas de la vitamina K (por contraindicaciones o negación), deben recibir aspirina (AAS). Lo que aporta esta nueva guía es que “en casos de contraindicación por riesgo de hemorragia, la combinación de aspirina y clopidogrel no está indicada porque dicho riesgo es similar a la de W (I;A)”. Añade que “es razonable que de requerirse la interrupción transitoria de W, utilizar heparinas de bajo peso molecular (HBPM)” (IIa/C).
· En pacientes con Insuficiencia Cardíaca (IC) con fracción de eyección deprimida de <35%, y en ritmo sinusal, “sigue sin estar claro los beneficios de anticoagular con W, en lugar de antiagregar con las opciones disponibles“ (recomendación IIb/B). El tratamiento con W, AAS, clopidogrel (CDG), combinación AAS/dipiridamol son opciones igual de eficaces en este contexto según la literatura actual disponible (IIb/B).
· En casos de estenosis del 50-99% por aterosclerosis de grandes vasos intracraneales se aconseja solo la antiagregación con AAS (I;A) y el control adecuado de la HTA y lípidos (IIb/B). La angioplastia con o sin colocación de stent aún se considera “en investigación” (IIb/B) y la cirugía de by-pass no se recomienda (III;B). En los casos de enfermedad vertebrobasilar extracraneal se aconseja el tratamiento médico adecuado (I;A), y en casos de fracaso del mismo, deben considerarse las opciones endovascular o quirúrgica (IIb/C).
· La recomendaciones en otros tópicos: tratamiento antiagregante y anticoagulante, foramen oval permeable (FOP), valvulopatía, hiperhomociteinemia, trombofilia, trombosis senos venosos y embarazo (EBZ) no han cambiado respecto del 2.006. Recordemos 3 puntos:
Ø Tratamiento antiagregante y anticoagulante. En el ictus isquémico no cardioembólico (aterotrombótico, de pequeños vasos, etc.), el tratamiento debe ser antiagregante (I;A); las primeras opciones: AAS 50-325 mg/día (I;A), AAS/dipiridamol 25/200 mg cada 12 hs (I;B), CDG 75 mg/día (IIa;B). La elección debe depender de los costos, preferencias, contraindicaciones, alergia, tolerancia, nivel de evidencia. En la recurrencia del ictus mientras se ingiere alguno de estos, habitualmente se cambia el antiagregante por otro de diferente mecanismo de acción, aunque no hay estudios que soporte la elección de uno sobre otro. Aumentar la dosis de AAS no demostró beneficios y combinarla con CPD no se recomienda (III;A).
Ø FOP: se propone solo antiagregar con AAS. No está claro aún que anticoagular sea mejor y tampoco que el cierre quirúrgico o endovascular sean eficaces.
Ø EBZ con riesgo trombótico elevado (trombofilias, válvula protésica) deben recibir anticoagulación durante todo el EBZ; opciones: heparina no fraccionada subcutánea cada 12 horas con control de KPTT, HBPM a dosis ajustadas según FXa, o heparina durante el primer trimestre y a partir de la mitad del tercero, y entre ambos, W. EBZ sin riego trombótico elevado, heparina el primer trimestre y luego AAS.
La enciclopedia más famosa de la web comenta que, en ámbitos militares, se denomina guía al “sargento que se coloca en la posición conveniente para la mejor alineación de la tropa”. Las guidelines pretenden llevar a cabo básicamente ese concepto: alinear a los médicos bajo conceptos concretos, basados en la evidencia disponible, para el manejo de una determinada enfermedad. Obviamente después, en la actividad cotidiana, los médicos “de trinchera” debemos discernir el manejo adecuado para cada uno de nuestros enfermos, sobre todo en las situaciones clínicas donde la evidencia científica tiene sus limitaciones. Las guías sólo deben ayudarnos a tratar mejor a nuestros pacientes.

Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack. A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:00-00

Efectos del desfasaje horario (Jet- Lag)

Efectos del desfasaje horario (Jet- Lag)
El desfasaje horario (jet lag) es un trastorno del sueño producido al cruzar con gran rapidez husos horarios alterando el reloj circadiano.

La inducción rápida de hipotermia tras el paro cardiaco es barata, sencilla y efectiva


REMI envía todos sus contenidos gratuitamente por correo electrónico a más de 8.700 suscriptores. [Suscripción]
Artículo nº 1586. Vol 1, enero 2011.
Autor: Eduardo Palencia Herrejón

La inducción rápida de hipotermia tras el paro cardiaco es barata, sencilla y efectiva

Artículo original: A rapid, safe, and low-cost technique for the induction of mild therapeutic hypothermia in post-cardiac arrest patients. Kory P, Weiner J, Mathew JP, Fukunaga M, Palmero V, Singh B, Haimowitz S, Clark ET, Fischer A, Mayo PH. Resuscitation 2010; 82(1): 15-20. [Resumen] [Artículos relacionados]

Introducción: La atención adecuada del paro cardiaco recuperado es esencial para conseguir la supervivencia libre de secuelas neurológicas [1]. Entre las medidas más útiles se encuentra la hipotermia terapéutica (HT); sin embargo, como ocurre con otras terapéuticas novedosas, la HT tarda en adoptarse por los profesionales [2]. Una de las razones que pueden influir en ello es la creencia de que la HT es una técnica compleja, difícil de adoptar y que requiere un aparataje sofisticado y caro, que no está disponible en muchos hospitales.

Resumen: En un estudio de cohortes retrospectivo, los autores evalúan los resultados de la aplicación de un protocolo hospitalario de inducción y mantenimiento de hipotermia en pacientes con paro cardiaco recuperado, cuyo objetivo fundamental es la rapidez en la obtención de la temperatura diana de 32-34º C, que una vez alcanzada se mantuvo durante 24 horas. La hipotermia se indujo mediante la infusión rápida de suero salino frío intravenoso hasta un total de 40 ml/kg, el enfriamiento de superficie mediante toallas empapadas con agua a temperatura ambiente y un ventilador, y lavados con agua fría por sonda orogástrica. Se incluyeron en el estudio los 65 paros cardiacos ingresados en la UCI en un periodo de tres años (tanto intra como extrahospitalarios). Todos los pacientes alcanzaron la temperatura deseada. Las medidas de enfriamiento se iniciaron de mediana 68 minutos tras la recuperación del pulso. El ritmo de enfriamiento fue de 2,6º C por hora. El tiempo mediano en alcanzar la temperatura diana fue de 134 minutos tras la recuperación del pulso, y de 60 minutos tras iniciar las medidas de enfriamiento. El 31% de los pacientes alcanzaron una buena recuperación cerebral (Cerebral Performance Category de 1 o 2). Las complicaciones fueron similares a las de otros estudios publicados.

Comentario: El estudio muestra que todo lo necesario para obtener óptimos resultados con la HT son un equipo bien organizado, un protocolo bien diseñado, suero salino, agua, toallas y un ventilador convencional. Las ventajas e inconvenientes relativos de los distintos métodos de enfriamiento tras el paro cardiaco no son bien conocidas, pero la no disponibilidad de aparataje específico no debe suponer una barrera para la aplicación de HT en ningún hospital.
Eduardo Palencia Herrejón
Hospital Universitario Infanta Leonor, Madrid
©REMI, http://remi.uninet.edu. Enero 2011.

Enlaces:
  1. Manejo del síndrome posparada cardíaca. Documento de Consenso de miembros del Comité Directivo del Plan Nacional de RCP de la SEMICYUC. Martin-Hernandez H, Lopez-Messa JB, Perez-Vela JL, Molina-Latorre R, Cardenas-Cruz A, Lesmes-Serrano A, Alvarez-Fernandez JA, Fonseca-San Miguel F, Tamayo-Lomas LM, Herrero-Ansola YP. Med Intensiva 2010; 34(2): 107-126. [PubMed]
  2. Mild therapeutic hypothermia after cardiac arrest - a nationwide survey on the implementation of the ILCOR guidelines in German intensive care units. Wolfrum S, Radke PW, Pischon T, Willich SN, Schunkert H, Kurowski V. Resuscitation 2007; 72(2): 207-213. [PubMed]
Búsqueda en PubMed:
  • Enunciado: Ensayos clínicos sobre hipotermia terapéutica en el paro cardiaco
  • Sintaxis: therapeutic hypothermia AND cardiac arrest AND clinical trial[ptyp]
  • [Resultados]
Palabras clave: Paro cardiaco, Hipotermia terapéutica.

New Sparkle for an Abstract Ensemble

ART REVIEW

New Sparkle for an Abstract Ensemble

SARATOGA SPRINGS, N.Y. — In the echo chamber that is the New York art world, where one voice can give the illusion of being many, the crusading cry of late is “We need more painting!” As if there were a dearth. Is there? Walk through any of the city’s art museums, and what do see? Paintings everywhere. Visit contemporary galleries all over town, and what do you find? They’re painting packed. But still the cry goes on.
Arthur Evans
“The Jewel Thief”: Top row, from left, Joan Snyder’s “And Always Searching for Beauty,” Stanley Whitney’s “Tango” and Michael Lazarus’s “Again” at the Tang Museum.

Blog

ArtsBeat
The latest on the arts, coverage of live events, critical reviews, multimedia extravaganzas and much more.Join the discussion.
LMAK Projects
A hanging chandelier, “Hybrid” (2009), by Virgil Marti and a wall installation, “Romancing the Rock” (2010), by Elana Herzog.
This is especially puzzling because much of the plenteous new work, while expertly schooled, looks unadventurous, like so many slightly rearranged cover versions of hit styles from the past: Geometric Abstraction, Surrealism, Hallmark Cards Expressionism, etc. Maybe we’re wrong to expect more. Maybe that’s all that painting, in New York at least now, can yield.
Or maybe we have a display problem. Exhibitions, which are intensely calculated events, can make powerful arguments for art. Ambitious, imaginatively conceived group shows in particular can significantly raise the interest level of even ordinary material and make the better than ordinary soar.
Such exhibitions are always hard to find, but there’s one on view now at the Frances Young Tang Teaching Museum and Art Gallery at Skidmore College here in upstate New York. Consisting mostly of paintings, and with work by 60 artists, it’s called “The Jewel Thief.” Piece by piece it’s a modest affair, but as an ensemble it’s vibrant. It makes even minimally interesting components feel vivacious.
Abstraction is the show’s unifying principle, but that covers a wide swath, and sets up some useful confusions. Painting dominates. Some of it is old (a 1950s Joan Mitchell, a 1970s Nicholas Krushenick), but most is from the last 10 years, and by artists of different generations. (Joan Snyder was born in 1940, Francesca DiMattio in 1981.) Stylistically the work is all over the map, and generally speaking innovation isn’t the point. Nuance is.
That nuance extends to how forms are defined. There are, for example, drawings in the show that look like painting, like a beautiful puff-of-smoke graphite piece by Jerry Phillips, and painting, like Richard Woods’s faux-wood floorboards, that is basically tinted drawing.
More surprisingly, there’s sculpture that’s distinctly painterly and draftsmanly. A ceramic piece by Kathy Butterly, covered with flowing and dripping glazes, is a knot of expressionistic color and gesture. The surface of a Styrofoam bench by James Hyde incorporates photographic details of a Stuart Davis painting. Three tall, thin, black wooden sculptures by Rico Gatson, set high on a balcony, read like ink strokes against a white wall.
Architecture plays a role in this game of identity switching. White cubes of different sizes are scattered around the Tang’s main gallery. The smaller ones serve as straightforward pedestals for sculptures like Ms. Butterly’s, but the larger ones are multipurpose. They function as space dividers, as walls for hanging paintings and, when covered with a hand-painted mural like Jim Hodges’s camouflage-patterned “Oh Great Terrain,” as art objects.
In this boundary-free environment no surface is pure, no form is sacrosanct. Thin lines of ripped fabric in a wall piece by Elana Herzog appear to be burning, like corrosive acid, in the cube they’re stapled to. And here and there art piles up on top of other art. In one case a small pencil drawing by the amazing Gary Batty — he’s the Michelangelo of near-microscopic crosshatching — is hung directly on a panel covered with an assertively patterned design in ink by Victoria Palermo.
Such doublings up point out a major strategy, and strength, of the show, organized by the Tang curator Ian Berry and the sculptor Jessica Stockholder. Throughout the installation, objects are placed in what promises to be clashing and undermining proximity, without any damage occurring. To the contrary, almost everything picks up something useful, often something it lacks — weirdness, beauty, weight, humility — from being in mixed company.
Ms. Stockholder’s sculpture has always operated within this dynamic, and does in two pieces she contributes to the exhibition. The smaller of them, “Chandelier of Sand and Oil,” an assemblage of electrical cords, fluorescent bulbs, drinking glasses and sea shells suspended from a thick metal chain, succinctly embodies her signature mix of found material, constructed form, and painterly color.
But it is her second and larger piece, called “The Jewel Thief,” that most fully expands on the show’s overarching aesthetic, an aesthetic that puts a premium on formal diversity and interdependence, and that questions the sovereign value assigned to the stand-alone art object in an object-glutted world.

Ms. Stockholder’s piece consists of several wooden and steel platforms that suggest small stages or disassembled bleachers. They’re clearly made for standing and sitting — a version of the piece was installed as an outdoor sculpture in Manhattan in 2009 — though one platform also serves as an outsize shelf for displaying two diminutive sculptures by Richard Rezac. One is a cluster of tubular maple uprights shaped like candles or organ pipes; the other, a kind of aluminum tray holding red and blue polyurethane cylinders that could be chess pieces or gemstones.
Above this platform hang jewel-like paintings in salon-style profusion: glowing grids of orange and red by Stanley Whitney; a shower of blossoms by Ms. Snyder; a tanka-type piece by Michael Lazarus with a citrus-and-dried-blood palette and little faces with cut-out eyes. One artist, Roy Dowell, is represented by several works: a half-dozen loquacious paint-pencil-and-collage pieces that dress Juan Gris in floral-print slip-cover fabrics and that capture the show’s high-low, serious-kidding, pretty-ugly soul.
Ordinarily I don’t find Mr. Dowell’s art all that gripping; there’s something generic about its slightly updated modernism. I feel the same about several other painters in the show who, to my eye, rejigger old models without adding much to them. But within the exhibition environment cooked up by Mr. Berry and Ms. Stockholder everybody takes on some sparkle, like guests mingling at a good party.
Mr. Dowell’s floral patterns, for instance, link up with and complement Mr. Hyde’s vinyl-covered Stuart Davis sofa: art museum meets suburban living room. And their work is gently lifted up — made more complex and joyous — by its connection to the spidery Christmas-lights chandelier by Virgil Marti hanging from the gallery ceiling, a marriage of grace and kitsch in excelsis.
Mr. Marti titles his work “Hybrid.” And that is, of course, what the Tang show is, though a hybrid so carefully shaped and thought through that it becomes something more. It’s essentially a big piece of Conceptual Art, one that messes with given definitions of painting, drawing, sculpture and architecture, and by doing so breaks those forms open. At the Museum of Modern Art in Manhattan, a smart exhibition called “On Line: Drawing Through the Twentieth Century” is doing much the same thing by recasting modern and contemporary drawing as a trans-disciplinary phenomenon encompassing painting, sculpture and performance.
Such shows, whatever flaws they may have in execution, make art history, past and present, bigger and richer. They bring more guests — some still strangers — to the table. And they assure that art in its many forms is productively refreshed and promoted. Given all of that, a dogged push for painting-only-painting, as if painting were the only art that’s really art, seems like an unnecessary, and deeply conservative crusade.
THE JEWEL THIEF
WHEN AND WHERE Through Feb. 27; Frances Young Tang Teaching Museum and Art Gallery, Skidmore College, 815 North Broadway, Saratoga Springs, N.Y.
MORE INFO (518) 580-8080, tang.skidmore.edu.
DINING IN SARATOGA SPRINGS Little India, 60 Court Street, (518) 583-4151,saratogalittleindiarestaurant.com; Maestro’s, 371 Broadway, (518) 580-0312,saratogamaestros.com; Ravenous, 21 Phila Street, (518) 581-0560, ravenouscrepes.com.

Failure in the Gulf

EDITORIAL

Failure in the Gulf

The document released Wednesday by the presidential commission investigating last spring’s oil blowout in the Gulf of Mexico is a riveting and chilling indictment of “systemic failures” throughout the oil business and of the federal agencies that allowed themselves to be captured by the people they were supposed to regulate.

The commission will offer specific recommendations for reform in its full report next Tuesday. But the chapter it decided to release early is, by itself, a powerful summons to the Obama administration to press rapidly forward with stronger regulations, and to the industry as a whole to behave far more responsibly than it has.
Another tragedy like the one in the Gulf of Mexico could well occur, the report suggests, unless there is “significant reform in both industry practices and government policies.”
The panel traced the blowout to three main factors:
MANAGERIAL FOUL-UPS: The most significant failure and “root cause” of the blowout was a seemingly endless series of fateful missteps and oversights by BP and its partners — Transocean and Halliburton — that, in retrospect, could have been avoided. These decisions included not installing enough devices to stabilize the well, not waiting for the results of tests on the foam used to seal the well, and ignoring the results of an important pressure test. Taken together, these and other blunders allowed gases to enter the well and rise with explosive and ultimately disastrous force to the drilling rig.
SYSTEMIC FAILURE: Though BP in particular has been accused of putting profit before safety, the report avoided linking any individual decision to cost considerations. Even so, BP and its partners repeatedly chose the riskier, speedier course instead of a slower and safer alternative. As Bob Graham, the commission co-chairman, noted in a separate statement, “This disaster likely would not have happened had the companies involved been guided by an unrelenting commitment to safety first.”
The report further asserted that this risk-taking was not unique to BP or its partners in the well, that the blowout was “not the product of a series of aberrational decisions” made by a rogue company, but, instead, reflected an industrywide proclivity for risky behavior. “Do we have a single company, BP, that blundered with fatal consequences,” asked the other co-chairman, William Reilly, “or a more pervasive problem of a complacent industry?” Sadly, Mr. Reilly said, it is the latter.
REGULATORY WEAKNESS: As expected, the panel took federal regulators in the old Minerals Management Service to task for a range of mistakes, like rubber-stamping drilling permits and failing to oversee operations on the rig. These failures are hardly new. For years, the service has had neither the will nor the resources to police the industry.
Since the blowout, the Obama administration has reorganized the regulatory apparatus to give it greater independence. It has also issued and is now enforcing specific safety regulations and increased surveillance on individual rigs. All this is welcome, but the administration has a long way to go. What is at issue here is nothing less than remaking the culture of an entire industry
.